Product Images Pregabalin
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 14 images provide visual information about the product associated with Pregabalin NDC 71205-556 by Proficient Rx Lp, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This is a medication called Pregabalin with a dosage of 50mg per capsule. The medication comes in a package with 30 capsules with a serial number and a lot number. The medication guide should be provided to each patient. The medication is white to off-white powder, filled in size "3" hard gelatin capsules with a white opaque colored cap and body. The cap has an imprint of "SG," and the body has an imprint of "#30 Capsules SNAMASTER 351" with black ink. The product is made by ScieGen Pharmaceuticals, Inc. and packed by Proficient Rx LP in Thousand Oaks, CA. The medication should be stored at 25°C (77°F), and the lot number provided is 00000.*
This text appears to be a table or chart containing medication dosages and results for patients' pain improvement. The top section shows different dosages for three different medications (Pregatalin, Pregabain, and Pregabalin) taken multiple times per day. The bottom section displays the percentage of improvement in pain for patients compared to their baseline pain levels. However, the text is not fully legible and there may be some errors in the result.*
The text provides a graph presenting the percentage of patients improvement with two different doses of Pregabalin - 300mg and 450mg, as well as a placebo, in comparison to the baseline pain. There is no further information available to provide a more useful description.*
This appears to be a chart with different subject percentages on the y-axis and days on the x-axis, labeled with two treatments: "Progabain" and "Placebo." However, without further context or information, it is not possible to determine the specifics of the study or what the percentages represent.*
The text provided is describing a chart or data representation that shows the percentage of subjects improved from Bassin to week 12 based on BOCF. The actual percentages are not available as the text only contains symbols and letters that do not form coherent words or numbers.*
This appears to be a formula for calculating creatinine clearance (CLCT) for patients based on their age, weight, and serum creatinine level. However, the value for "mmmmmmmmm e e" is not readable and may have been incorrectly translated by the . Therefore, the formula is not entirely complete and may not be usable without additional context or information.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.